Corticosteroids, But Not TNF Antagonists, Are Associated With Adverse COVID-19 Outcomes in Patients With Inflammatory Bowel Diseases: Results From an International RegistryErica J. Brenner, Michael D. Kappelman, Michele Kissous-Hunt et al.|Gastroenterology|2020Cited by 692
Outcomes following SARS-CoV-2 infection in patients with chronic liver disease: An international registry studyThomas Marjot, Gwilym J. Webb, Andrew M. Moon et al.|Journal of Hepatology|2020Cited by 525